Nemaura Medical Inc. (NMRD)
OTCMKTS: NMRD · Delayed Price · USD
0.105
+0.073 (229.06%)
Jul 18, 2024, 4:00 PM EDT - Market closed
Nemaura Medical Market Cap
Nemaura Medical has a market cap or net worth of $4.25 million as of July 22, 2024. Its market cap has decreased by -91.31% in one year.
Market Cap
4.25M
Enterprise Value
23.75M
1-Year Change
-91.31%
Ranking
n/a
Category
Stock Price
$0.11
Market Cap Chart
Since December 18, 2014, Nemaura Medical's market cap has decreased from $500.00M to $4.25M, a decrease of -99.15%. That is a compound annual growth rate of -40.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 4, 2024 | 3.00M | -52.38% |
| Dec 29, 2023 | 6.30M | -84.78% |
| Dec 30, 2022 | 41.40M | -61.05% |
| Dec 31, 2021 | 106.30M | 23.03% |
| Dec 31, 2020 | 86.40M | 18.68% |
| Dec 31, 2019 | 72.80M | -60.56% |
| Dec 31, 2018 | 184.60M | -82.34% |
| Dec 29, 2017 | 1.05B | 240.00% |
| Dec 30, 2016 | 307.50M | -12.14% |
| Dec 31, 2015 | 350.00M | -63.16% |
| Dec 31, 2014 | 950.00M | 90.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |